End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,940 KRW | +0.94% |
|
+5.53% | -23.24% |
May. 22 | Dong-A ST to Become Second-Largest Shareholder of Idience in KRW25 Billion Deal | MT |
2023 | Il Dong Pharmaceutical Eyes Approval for to Manufacture Japan's COVID-19 Treatment in South Korea | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-23.24% | 283M | |
+62.66% | 854B | |
+40.42% | 636B | |
-4.37% | 361B | |
+17.16% | 324B | |
+9.87% | 301B | |
+15.66% | 247B | |
+4.21% | 230B | |
+17.90% | 228B | |
+14.86% | 177B |
- Stock Market
- Equities
- A249420 Stock
- News Ildong Pharmaceutical Co., Ltd.
- Il Dong Pharmaceutical Starts Clinical Trial of COVID-19 Drug